PharmaTimes -
June 2018

The 2018 Communications Team of the Year awards are now open for entry, so on p32 we thought we’d ask some top pharma communicators what trends and issues comms teams need to be paying attention to right now. (And given that they’re all on the CTOY steering committee, those of you thinking of entering might want to pay attention!)

Speaking of competitions, the past month has seen both of our Clinical Researcher awards revealing their winners, and we have full coverage on p36-39.

Elsewhere in the mag we take a look at the hurdles biosimilars still need to overcome to reach their full potential in the market (p30), the current state of gene therapy (p22), GSK’s financial woes (p20) and what could be the first marketed treatment for traumatic brain injury (p28).

June 2018 - magazine highlights

Thumbnail image for The ultimate cure?

The ultimate cure?

Gene therapy still needs to overcome some major hurdles to truly fulfil its promise

Thumbnail image for Together as one

Together as one

We caught up with IQVIA’s SVP global technology solutions, Tal Rosenberg, at the 2018 eyeforpharma Barcelona conference as the company announced the EU launch of its Orchestrated Customer Engagement product, which aims to harmonise pharma's interaction with customers

Thumbnail image for Company focus: Vasopharm

Company focus: Vasopharm

CEO Christian Wandersee explains the hurdles and hopes when developing drugs for traumatic brain injury, a devastating condition for which there is no existing drug treatment

Thumbnail image for On the comms radar

On the comms radar

Pharma comms is one of the most dynamic  sectors of the industry. So, what should  be on communicators’ radar?

Latest jobs

View all

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download